Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:190728-25-7
Molecular Formula:C17H16N2O3
Alias
More Information
Benzenamine,4-[(6,7-Dimethoxy-4-Quinolinyl)oxy]-; [4-[(6,7-Dimethoxyquinolin-4-yl)oxy]Phenyl]Amine; 4-[(6,7-Dimethoxyquinolin-4-yl)oxy]Aniline;6,7-Dimethoxy-4-(4-Aminophenoxy)Quichemicalbooknoline; Benzemine,4-[(6,7-Dimethoxy-4-Quinolinyl)oxy]-; 4-[(6,7-Dimethoxy-4-Quinolinyl)oxy]-Benzenamine;4-(2,3-Dimethoxynaphthalen-5-Yloxy)Benzenamine; Intermediate1Ofcabozantinib
CAS:1229022-83-6
Brief Introduction
Secukinumab is a high-affinity monoclonal antibody directed against interleukin (IL-17A). Secukinumab (AIN457) is a first-in-class anti-IL-17 agent studied in plaque psoriasis, ankylosing spondylitis and psoriatic arthritis.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!